During the trading day today, I tweeted the following:
IWSY has been a position I have been in and out of numerous times over the past year after publishing research on the name when it was trading below $1. It has been a profitable investment overall, although lately the company has been grinding in a sideways range.
I would like to hold onto a position in IWSY from this point, perhaps into the end of the year. I believe that revenues are about to ramp, as is recognition of the company as the leader in multimodal biometrics. It is not a matter of IF IWSY becomes an acquisition target by a large, well heeled technology company, but rather WHEN. In the meantime, you get the revenue ramp as the catalyst not only to an increase in value overall, but an increase in recognition of the company, which will feed the eventual acquisition of this name. A classic virtuous cycle.
I will go into the reasons why I believe revenues are set to ramp, as well as other catalysts that are becoming apparent, in the monthly report I send to investors, to be published at the end of June. Increasingly, I am keeping the monthly report/summary as an email only type deal. I'm giving away too much information about the portfolios I manage to simply post it publicly. I will continue to post the report from time to time. However, the monthly summary postings on this site will be more infrequent in nature.
If you haven't joined the email list, you may do so by getting in touch with me at mail@T11Capital.com
As of the close today, managed portfolios are invested in four positions: IWSY, WMIH, HH and KFS.
Simplicity has and will always rule.
